Calendar Supernus Pharmaceuticals, Inc.

Equities

SUPN

US8684591089

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
30.07 USD +2.59% Intraday chart for Supernus Pharmaceuticals, Inc. +2.28% +3.90%

Chart calendar Supernus Pharmaceuticals, Inc.

59ef20c7af89ed13a9b1b75.VltZgOQpIAQrCrn1D7RQG6UqV8Qw2jVXLy-jilMX_Bk.BjYG2It_GWNIVeCsX8VkdcF9J71AvmQNH1fivRE6mEpgOQzUt0t_ZRpy_A~36b7af8494ce6c12d996a027c4c4e6fc

Upcoming events on Supernus Pharmaceuticals, Inc.

08/05/2024 21:05 Q1 2024 Earnings Release
08/05/2024 21:30 Q1 2024 Earnings Call
14/06/2024 15:00 Annual General Meeting
05/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Supernus Pharmaceuticals, Inc.

13/03/2024 19:35 Barclays Global Healthcare Conference
11/03/2024 Jefferies Biotech on the Bay Summit
06/03/2024 14:10 TD Cowen Health Care Conference
27/02/2024 21:30 Q4 2023 Earnings Call
27/02/2024 21:05 Q4 2023 Earnings Release
15/11/2023 14:00 Jefferies London Healthcare Conference
08/11/2023 21:30 Q3 2023 Earnings Call
08/11/2023 21:05 Q3 2023 Earnings Release
18/10/2023 13:30 R&D Day
06/09/2023 16:00 Wells Fargo Healthcare Conference
08/08/2023 21:30 Q2 2023 Earnings Call
08/08/2023 21:05 Q2 2023 Earnings Release
16/06/2023 15:00 Annual General Meeting
07/06/2023 18:00 Jefferies Global Healthcare Conference
11/05/2023 18:40 Bank of America Healthcare Conference - Fireside Chat
09/05/2023 21:30 Q1 2023 Earnings Call
09/05/2023 21:05 Q1 2023 Earnings Release
15/03/2023 Jefferies Biotech on the Bay Summit
14/03/2023 Barclays Global Healthcare Conference
07/03/2023 14:50 Cowen Health Care Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
393
399
-1.62%
520
523
-0.5%
580
579
0.19%
667
680
-1.92%
608
598
1.55%

601

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
192
167
14.87%
119
103
15.17%
129
130
-0.82%
97,3
91,2
6.67%

91,4

EBIT
Million USD
Released
Forecast
Spread
149
150
-0.75%
174
172
0.79%
86,0
107
-19.26%
46,1
40,0
15.17%
125
104
20.75%

106

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
147
148
-0.2%
169
171
-1.16%
73,2
93,6
-21.84%
60,7
54,6
11.33%
2,77
0,67
310.83%

5,86

Net income
Million USD
Released
Forecast
Spread
113
112
1.28%
127
128
-0.72%
53,4
66,3
-19.37%
60,7
95,2
-36.26%
1,32
-1,22
207.52%

7,23

EPS
USD
Released
Forecast
Spread
2,10
2,07
1.55%
2,36
2,38
-0.74%
0,98
1,21
-19.18%
1,04
1,11
-5.88%
0,02
-0,06
133.33%

-0,01

Announcement Date25/02/2025/02/2113/04/2228/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
159
159
-0.03%
153
150
1.35%
170
164
3.55%
177
172
2.83%
167
180
-7.23%
154
139
10.6%
136
144
-5.63%
154
143
7.32%
164
155
5.99%

146


149


154


152


153

EBITDA
Million USD
Released
Forecast
Spread



22,6
15,7
44.33%
32,0
20,9
53.39%
19,1
20,1
-5.03%
55,0
48,9
12.54%
25,1
6,57
282.68%
2,52
7,81
-67.71%
29,4
4,49
555.07%
40,3
20,4
97.41%

13,8


17,7


26,5


16,9




EBIT
Million USD
Released
Forecast
Spread
6,10
24,3
-74.91%
1,97
21,6
-90.87%
11,3
19,9
-42.85%
-1,52
-0,87
-75.66%
34,3
28,3
21.5%
30,5
23,4
30.34%
10,0
14,5
-30.98%
8,14
6,73
20.85%
47,1
26,3
78.76%

22,9


24,2


29,4


29,8


34,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2,05
19,3
-89.37%
14,7
25,3
-41.81%
11,3
21,2
-46.46%
-0,44
27,8
-101.59%
35,1
34,3
2.39%
9,02
-12,9
169.74%
-17,1
-11,7
-46.48%
9,89
-15,0
165.86%
0,99
-1,11
189.59%

-3,48


0,44


9,22


-0,32




Net income
Million USD
Released
Forecast
Spread
2,44
12,9
-81.01%
25,6
13,1
95.92%
7,87
18,1
-56.45%
1,75
21,9
-92%
25,5
28,2
-9.6%
16,9
-16,0
206.13%
-0,83
-14,4
94.25%
-16,0
-15,7
-1.62%
1,18
-1,37
186.08%

-4,30


0,54


11,4


-0,39




EPS
USD
Released
Forecast
Spread
0,04
0,24
-83.1%
0,43
0,45
-4.44%
0,14
0,29
-51.72%
0,03
0,36
-91.59%
0,43
0,52
-16.77%
0,29
-0,26
211.54%
-0,02
-0,23
91.3%
-0,29
-0,29
0%
0,02
-0,02
200%

-0,08


0,01


0,20


-0,01




Announcement Date13/04/2209/05/2204/08/2208/11/2228/02/2309/05/2308/08/2308/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SUPN Stock
  4. Calendar Supernus Pharmaceuticals, Inc.